Hugel

Hugel Current Ratio

The Current Ratio of Hugel (145020.KQ) as of Oct 19, 2026 is 8.60. In the previous year, Current Ratio was 48.09 — a change of -82.11% (lower).

Current Ratio

8.60

YoY

-82.11%

Last updated:

Current Ratio of Hugel is 2025 8.60 . Current Ratio of Hugel was 2024 48.09 . It decreases by -82.11% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hugel Stock analysis

What does Hugel do? Hugel Inc is a biotechnology company based in Chuncheon, South Korea, operating in the Health Care sector. It manufactures and sells biopharmaceuticals, including botulinum toxins for treating benign essential blepharospasm and moderate to severe glabellar lines in 50, 100, and 200 unit types. The company also produces hyaluronic acid fillers for facial wrinkles under various product lines such as Chaeum Premium and Chaeum MID. Hugel Inc went public on December 24, 2015, and markets its products domestically and internationally. Its website is http://www.hugel.co.kr/ Hugel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hugel stock

Current Ratio of Hugel is 8.60 in 2025.

Current Ratio of Hugel changed from 48.09 to 8.60, representing a -82.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Hugel since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Hugel with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hugel

All Key Metrics — Hugel